NEW YORK (Reuters Health) – In a study of critically ill adults, use of chlorhexidine gluconate-impregnated sponges for dressings significantly reduced the risk of catheter-related infections compared with…
NEW YORK (Reuters Health) – In patients with chronic hepatitis C genotype 4, adding nitazoxanide to peginterferon alfa-2a and ribavirin improves the virologic response rates, new research shows.…
NEW YORK (Reuters Health) – Using a novel high-throughput screening assay, a team of scientists has discovered that two highly virulent viruses are susceptible in vitro to the…
NEW YORK (Reuters Health) – As a treatment for chronic hepatitis B, telbivudine produces a better therapeutic response than does lamivudine in both HBeAg-positive and –negative patients, according…
Jorge D. Reyes, MD, Director of Transplant Program, Seattle Children’s Hospital and Regional Medical Center, discusses the issues surrounding CMV prophylaxis in pediatric transplant recipients. References and Resources…
NEW YORK (Reuters Health) – In those relatively rare “slow-progressing” HIV-infected patients who mount an effective immune response to the infection, the neutralizing activity is made up of…
NEW YORK (Reuters Health) – Although the incidence of health care-associated Clostridium difficile infections remained stable in Canada between 1997 and 2005, the attributable mortality nearly quadrupled, according…
Organic chemist professor Edward Biehl PhD , Professor and Chair, Department of Chemistry, Southern Methodist University, discusses the discovery of a new compound that aims to prevent neurodegeneration…
NEW YORK (Reuters Health) – The seroprevalence of Coxiella burnetii – the causative organism of the zoonotic disease Q-fever – is high among US veterinarians, particularly those who…
NEW YORK (Reuters Health) – There appears to be no temporal association between Guillain-Barre syndrome and influenza vaccination. However, influenza-like illness and Guillain-Barre does show such a link,…